Bahrain Pharmaceuticals & Healthcare Q3 2019
Growth in Bahrain's pharmaceutical market will remain limited by its unfavourable risk profile. Opportunities exist formanufacturers willing to invest in a small yet high-risk market, yet the dominance of larger players in the Gulf region will derail anymeaningful investment away from Bahrain's underdeveloped market. Furthermore, we believe that the measures proposed underthe Bahrain’s new National Employment Programme (NEP), if approved by parliament, could potentially weaken Bahrain’sattractiveness as a foreign investment destination. Tighter restrictions on expatriate hiring may increase overall labour costs,impacting revenue of drugmakers operating in the country.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook